Headlines about SeaSpine (NASDAQ:SPNE) have trended somewhat positive on Monday, according to Accern. Accern identifies positive and negative press coverage by analyzing more than 20 million blog and news sources in real-time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. SeaSpine earned a news impact score of 0.11 on Accern’s scale. Accern also gave news articles about the medical equipment provider an impact score of 47.0447879099988 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the next few days.
A number of research analysts have recently issued reports on SPNE shares. Zacks Investment Research lowered SeaSpine from a “buy” rating to a “hold” rating in a research report on Friday, January 5th. Ladenburg Thalmann Financial Services assumed coverage on SeaSpine in a research note on Thursday, December 14th. They issued a “buy” rating and a $20.00 price objective for the company. BTIG Research reissued a “buy” rating and issued a $17.00 price objective on shares of SeaSpine in a research note on Friday, March 2nd. Finally, HC Wainwright set a $15.00 price objective on SeaSpine and gave the company a “buy” rating in a research note on Friday, March 2nd. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating and four have given a buy rating to the stock. The stock has a consensus rating of “Buy” and a consensus target price of $17.20.
SeaSpine stock traded down $0.02 during midday trading on Monday, reaching $9.95. The company had a trading volume of 3,467 shares, compared to its average volume of 36,701. SeaSpine has a 1 year low of $6.87 and a 1 year high of $13.46. The firm has a market cap of $144.94, a P/E ratio of -3.81 and a beta of 0.36.
COPYRIGHT VIOLATION WARNING: “SeaSpine (SPNE) Given Daily News Sentiment Score of 0.11” was first posted by Ticker Report and is the property of of Ticker Report. If you are accessing this story on another publication, it was illegally copied and reposted in violation of US and international trademark & copyright law. The legal version of this story can be read at https://www.tickerreport.com/banking-finance/3278775/seaspine-spne-given-daily-news-sentiment-score-of-0-11.html.
SeaSpine Company Profile
SeaSpine Holdings Corporation is a medical technology company. The Company is focused on the design, development and commercialization of surgical solutions for the treatment of patients suffering from spinal disorders. The Company operates through the development, manufacture and marketing of orthobiologics and spinal fusion hardware segment.
Receive News & Ratings for SeaSpine Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SeaSpine and related companies with MarketBeat.com's FREE daily email newsletter.